Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taliossa is a Singapore-based advisory and investment firm focused on innovation, system transformation, and growth strategy, with a meaningful emphasis on digital health, personalized health, and health equity. The company appears to operate primarily as a strategic advisor, ecosystem builder, and investor rather than as a therapeutic drug developer. Public profiles associated with managing director Tony Estrella describe Taliossa as supporting health technology companies across Asia and working in areas such as population health, cancer, brain health, sleep science, and longevity. Available evidence suggests the firm helps organizations with market exploration, partnership strategy, pilot design, and scaled execution. It does not appear to have a disclosed internal drug pipeline or clinical-stage therapeutic assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taliossa.